We return to our discussion with Ken Getz of the Tufts CSDD for part 2 of our blog post on key challenges in clinical trial operations. You can find Part 1 of the interview here, or read on to gain his insights on the fundamental problem at the heart of clinical trial operations challenges, and his views on the initiatives and programs that he believes show the most promise for the future.
Interview with Ken Getz: Exploring Challenges of Clinical Trial Operations Part 2
Posted by Cytel
Apr 13, 2018 7:21:00 AM
Topics: enforesys, forecasting, patient enrollment, clinical trials
Interview with Ken Getz: Exploring Challenges of Clinical Trial Operations Part 1
Posted by Cytel
Apr 5, 2018 8:30:00 AM
Photo by J. Kelly Brito on Unsplash
Research on clinical trial enrollment makes for sobering reading, characterized by the oft-cited statistic that 11% of active sites fail to enroll a single patient. In this first part of a two part interview, we sit down for a discussion with Ken Getz of the Tufts CSDD. Here, Mr. Getz expands on some of the Center’s more recent research on challenges in...
Topics: enforesys, forecasting, patient enrollment, clinical trials
5 Scenarios When ‘Keep it Simple’ May Be Bad Advice for Clinical Trial Designers
Posted by Esha Senchaudhuri
Sep 18, 2014 10:44:00 AM
When designing clinical trials, many trial designers are advised to keep the trial simple. Prima facie, the keep it simple principle seems like sound advice. There are various logistical uncertainties that arise when implementing a clinical trial, and the more simple a trial – so conventional wisdom says – the easier it is to respond to these uncertainties.
According to Zoran Antonijevic, a...
Topics: Oncology, Promising Zone, sample size re-estimation, Enrichment, Cytel Consulting, Efficacy, Interim Analyses, forecasting, optimization, Program and Portfolio Optimization, R&D, Adaptive Clinical Trials
In anticipation of Cyrus Mehta’s webinar next week on new predictive analytics tools for trial forecasting, we thought we might give you a few introductory notes on the nature and purpose of Predicted Interval Plots (better known as PIPs).
What are PIPs?
Topics: Trial Design, East PREDICT, Predicted Interval Plots, forecasting
The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics. Sign up for updates direct to your inbox. You can unsubscribe at any time.
Posts by Topic
- biostatistics (96)
- Adaptive Clinical Trials (82)
- Statistical Programming (56)
- Clinical Research Services (51)
- Clinical Development Strategy (47)
- adaptive designs (46)
- Oncology (40)
- Clinical Data (38)
- adaptive trials (35)
- Statistical Analysis (32)
- Data Management (31)
- Bayesian Methods (30)
- clinical trials (27)
- Cytel Strategic Consulting (25)
- Trial Design (23)
- CDISC (22)
- clinical research (21)
- Cytel Consulting (20)
- Early Phase Trials (20)
- Phase 3 (20)
- East (19)
- Interim Analyses (19)
- pharmacometrics (19)
- Phase 1 (18)
- phase 2 (18)
- Regulation (17)
- data manager (17)
- SDTM (16)
- careers (16)
- clinical development (16)
- data science (16)
- EAST 6.4 (15)
- EDC (15)
- SAS (15)
- patient enrollment (15)
- Cyrus Mehta (14)
- Dose-Escalation (14)
- Simulations (13)
- CRO (12)
- Dose-Finding (12)
- FDA (12)
- Program and Portfolio Optimization (12)
- Promising Zone (12)
- Statistical Innovations in Clinical Development (12)
- database build (12)
- pharmacology (12)
- Cardiovascular (11)
- adaptive sample size re-estimation (11)
- Biometrics (10)
- Entrepreneurship (10)
- Recruitment (10)
- ADaM (9)
- Precision Medicine (9)
- big data (9)
- clinical data management (9)
- outsourcing (9)
- Access to Slides PDF (8)
- Bayesian (8)
- CDM (8)
- East 6.3 (8)
- R programming (8)
- Trial Quality (8)
- go-no-go (8)
- sample size re-estimation (8)
- Case Study (7)
- Multi-Arm Multi-Stage Studies (7)
- Multi-Arm Studies (7)
- Phase I (7)
- Software Simulations (7)
- enforesys (7)
- model-informed-drug-development (7)
- quantitative decision-making (7)
- BLRM (6)
- DMC (6)
- East ESCALATE (6)
- East PREDICT (6)
- Enrichment (6)
- Nitin Patel (6)
- R language (6)
- Training and Education (6)
- feasibility studies (6)
- Biomarkers (5)
- Cytel Videos (5)
- MCP-Mod (5)
- Marvin Zelen (5)
- R (5)
- Sample Size (5)
- real world evidence (5)
- ACES (4)
- Access to Paper PDF (4)
- CDASH (4)
- CRM (4)
- Exact Tests (4)
- Prediction (4)
- Predictive Enrichment (4)
- Rare Disease (4)
- Rstats (4)
- Safety (4)
- Seamless designs (4)
- Small Sample Sparse Data (4)
- StatXact (4)
- Trial Design Software (4)
- Trial Monitoring (4)
- forecasting (4)
- randomization (4)
- Cytel Events (3)
- Dose Selection (3)
- Group Sequential (3)
- JSM (3)
- PK/PD (3)
- PSI Conference (3)
- PhUSE (3)
- Proof-of-Concept (3)
- R&D (3)
- Simulation & Biomarkers (3)
- Statistical Puzzles (3)
- White Paper (3)
- basket trials (3)
- custom software (3)
- exact statistics (3)
- genetic algorithm (3)
- machine learning (3)
- meta-analysis (3)
- optimization (3)
- p value (3)
- type 1 error (3)
- Adaptive Finance (2)
- Blind and Unblind Trials (2)
- Compass (2)
- Computing (2)
- EMA (2)
- Education (2)
- Efficacy (2)
- Lingyun Liu (2)
- Medical Devices (2)
- Monte Carlo (2)
- Movers & Shapers (2)
- NONMEM (2)
- PMDA (2)
- Pediatric (2)
- biomedical signals (2)
- estimands (2)
- patientricity (2)
- personalized medicine (2)
- pharmacovigilance (2)
- psychiatry and neuroscience (2)
- signal detection (2)
- trial planning (2)
- Adaptive Licensing (1)
- Antibiotic resistance (1)
- Biosimilars (1)
- Composite Endpoints (1)
- Cytel CliPLab (1)
- Cytel Congratulates (1)
- East Recruit (1)
- Eearly Development (1)
- Evidence Based Medicine (1)
- Exact Inference (1)
- Exact tests for categorical data (1)
- FMCG (1)
- Fourier (1)
- HTA (1)
- ISE (1)
- ISS (1)
- Infectious Diseases (1)
- NICE (1)
- PIPE (1)
- PSI (1)
- Predicted Interval Plots (1)
- RFP (1)
- Richard Branson (1)
- Risk Based Monitoring (1)
- Sam Hsaio (1)
- Scope conference (1)
- Statistics Article full PDF (1)
- Translational Medicine (1)
- Translational Statistics (1)
- Webinar Slides (1)
- What are... (1)
- benefit risk assessment (1)
- feature selection (1)
- health economics (1)
- immunotherapy (1)
- infographic (1)
- medical ethics (1)
- medical writing (1)
- non parametric analysis (1)
- pattern recognition (1)
- permutations (1)
- population enrichment (1)
- signal processing (1)
- statistical communication (1)
- subgroup analysis (1)
- t-tests (1)
- time to event trials (1)
- time-to-even trials (1)
- treatment switch (1)
- webinar (1)